Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza Immunization (Healthy Volunteers)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01311817
What this trial is testing

Transcutaneous Immunization With an Attenuated Listeria Monocytogenes Vector Vaccine

Who this might be right for
Healthy Volunteers
Massachusetts General Hospital 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT06907511
What this trial is testing

Study to Evaluate the Safety and the Immunogenicity of a Second Generation Structurally Designed mRNA Vaccine Candidate Against Pandemic Influenza H5 HA Strain in Healthy Adult Participants Aged 18 Years and Older

Who this might be right for
Pandemic Influenza ImmunizationHealthy Volunteers
Sanofi 720
Large-scale testing (Phase 3)Study completedNCT02114255
What this trial is testing

Effects of BCG on Influenza Induced Immune Response

Who this might be right for
Influenza Virus InfectionTrained Immunity
Radboud University Medical Center 40
Large-scale testing (Phase 3)Study completedNCT00464672
What this trial is testing

Safety, and Immunogenicity of Two Influenza Vaccines in Healthy Subjects 3 to 64 Years Old

Who this might be right for
Influenza
Novartis 1,893
Testing effectiveness (Phase 2)Study completedNCT01578317
What this trial is testing

Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 43
Testing effectiveness (Phase 2)UnknownNCT06294262
What this trial is testing

Safety, Tolerability, Immunogenicity and Immunological Mechanisms of TETRALITE, a Novel Seasonal Influenza Vaccine

Who this might be right for
Vaccination Reaction
LiteVax BV 84
Not applicableStudy completedNCT05313451
What this trial is testing

Evaluation of the Effect of a Soluble Fiber Consumption on Immunity Response

Who this might be right for
Immune Response
CEN Biotech 70
Not applicableNot Yet RecruitingNCT06694025
What this trial is testing

Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.

Who this might be right for
ImmunizationInfluenza (Healthy Volunteers)
Sanofi 670
Not applicableStudy completedNCT06059456
What this trial is testing

Safety Surveillance of VaxigripTetra® and Efluelda® Influenza Vaccines in Europe During the Influenza Season 2023/24

Who this might be right for
Influenza Immunization (Healthy Volunteers)
Sanofi 2,078
Not applicableStudy completedNCT00995527
What this trial is testing

Characterization of the Innate Immune Response in Healthy NIH Employees at Baseline and After Immunization With the H1N1 Vaccine

Who this might be right for
Healthy Volunteers
National Heart, Lung, and Blood Institute (NHLBI) 26
Not applicableEnded earlyNCT00769002
What this trial is testing

PET-CT Scans in Healthy Volunteers After Flu Vaccination

Who this might be right for
Flu
Hackensack Meridian Health 18
Early research (Phase 1)Study completedNCT00947687
What this trial is testing

Safety and Efficacy Study of Inhaled PUR003 on a Controlled Influenza Virus Challenge in Healthy Adult Subjects

Who this might be right for
Healthy
Pulmatrix Inc. 24
Testing effectiveness (Phase 2)Study completedNCT04969276
What this trial is testing

Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 306
Early research (Phase 1)Study completedNCT05426174
What this trial is testing

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi Pasteur, a Sanofi Company 233
Testing effectiveness (Phase 2)Study completedNCT02649192
What this trial is testing

Influenza Virus Vaccine Plus Vitamin A and D Supplements for Prevention of Respiratory Virus Infections in Children

Who this might be right for
Healthy Participants
St. Jude Children's Research Hospital 87
Not applicableNot Yet RecruitingNCT07282795
What this trial is testing

Post-marketing Surveillance Study for the Safety of Efluelda® Pre-filled Syringe

Who this might be right for
Influenza ImmunizationHealthy Volunteers
Sanofi 670
Early research (Phase 1)Study completedNCT00812019
What this trial is testing

Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)

Who this might be right for
Influenza
Seqirus 753
Early research (Phase 1)Study completedNCT00240903
What this trial is testing

Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 37
Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Not applicableStudy completedNCT00069914
What this trial is testing

Immune Response to Influenza Vaccine in HIV-Infected Individuals

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 165
Next Page